138 related articles for article (PubMed ID: 8596539)
1. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation.
Sato M; Nishigori C; Yagi T; Takebe H
Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539
[TBL] [Abstract][Full Text] [Related]
2. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A.
Tanioka M; Budiyant A; Ueda T; Nagano T; Ichihashi M; Miyachi Y; Nishigori C
J Invest Dermatol; 2005 Aug; 125(2):244-6. PubMed ID: 16098033
[TBL] [Abstract][Full Text] [Related]
3. Two novel splicing mutations in the XPA gene in patients with group A xeroderma pigmentosum.
Satokata I; Uchiyama M; Tanaka K
Hum Mol Genet; 1995 Oct; 4(10):1993-4. PubMed ID: 8595429
[No Abstract] [Full Text] [Related]
4. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein.
States JC; McDuffie ER; Myrand SP; McDowell M; Cleaver JE
Hum Mutat; 1998; 12(2):103-13. PubMed ID: 9671271
[TBL] [Abstract][Full Text] [Related]
5. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
States JC; Myrand SP
Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.
Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H
Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686
[TBL] [Abstract][Full Text] [Related]
7. Effect of XPA gene mutations on UV-induced immunostaining of PCNA in fibroblasts from xeroderma pigmentosum group A patients.
Miura M; Sasaki T
Mutat Res; 1996 Sep; 364(1):51-6. PubMed ID: 8814338
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype.
Negishi I; Kato G; Moriwaki S; Ishikawa O
Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522
[TBL] [Abstract][Full Text] [Related]
9. Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids.
Levy DD; Saijo M; Tanaka K; Kraemer KH
Carcinogenesis; 1995 Jul; 16(7):1557-63. PubMed ID: 7614689
[TBL] [Abstract][Full Text] [Related]
10. Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids.
Myrand SP; Topping RS; States JC
Carcinogenesis; 1996 Sep; 17(9):1909-17. PubMed ID: 8824513
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
12. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities.
Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S
Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812
[TBL] [Abstract][Full Text] [Related]
13. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.
Satokata I; Tanaka K; Yuba S; Okada Y
Mutat Res; 1992 Mar; 273(2):203-12. PubMed ID: 1372103
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the human xeroderma pigmentosum group A gene and their impact on cell survival and nucleotide excision repair.
Mellon I; Hock T; Reid R; Porter PC; States JC
DNA Repair (Amst); 2002 Jul; 1(7):531-46. PubMed ID: 12509227
[TBL] [Abstract][Full Text] [Related]
15. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
[TBL] [Abstract][Full Text] [Related]
16. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk.
Khan SG; Metin A; Gozukara E; Inui H; Shahlavi T; Muniz-Medina V; Baker CC; Ueda T; Aiken JR; Schneider TD; Kraemer KH
Hum Mol Genet; 2004 Feb; 13(3):343-52. PubMed ID: 14662655
[TBL] [Abstract][Full Text] [Related]
17. Mutation and expression of the XPA gene in revertants and hybrids of a xeroderma pigmentosum cell line.
Cleaver JE; McDowell M; Jones C; Wood R; Karentz D
Somat Cell Mol Genet; 1994 Jul; 20(4):327-37. PubMed ID: 7974007
[TBL] [Abstract][Full Text] [Related]
18. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
Kondoh M; Ueda M; Ichihashi M
Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
[TBL] [Abstract][Full Text] [Related]
19. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of a function of xeroderma pigmentosum group A (XPA) protein in strand-specific DNA repair.
Kobayashi T; Takeuchi S; Saijo M; Nakatsu Y; Morioka H; Otsuka E; Wakasugi M; Nikaido O; Tanaka K
Nucleic Acids Res; 1998 Oct; 26(20):4662-8. PubMed ID: 9753735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
